ELCO Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,109
Closed -$288K 162
2024
Q4
$288K Buy
+2,109
New +$288K 0.15% 122